Because MGO-induced inflammation plays an important role in the development of peritoneal fibrosis through the production of TGF-β1, the protective effects of linagliptin may be mediated by the attenuation of inflammation. This evidence concerns the gene TGFB1 and Peritoneal Fibrosis.